Lyra Therapeutics (LYRA) Insider Trading & Ownership → The World’s Richest Man Blindsided by AI (From Banyan Hill Publishing) (Ad) Free LYRA Stock Alerts $0.37 +0.01 (+2.59%) (As of 04:31 PM ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Lyra Therapeutics (NASDAQ:LYRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage17.42%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$13.45 MNumber OfInsiders Selling(Last 12 Months)0 Get LYRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Lyra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LYRA Insider Buying and Selling by Quarter Ad Chaikin AnalyticsDid Intel Just Dethrone Nvidia?Intel (INTC) just announced a brand-new AI venture - the Aurora supercomputer. This computer was specifically designed for artificial intelligence and is now the fastest AI-centered computer on the planet. You can get all the details here. Lyra Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/10/2023Harlan WaksalInsiderBuy25,000$2.96$74,000.00 5/31/2023Nbvm Gp, LlcMajor ShareholderBuy1,805,416$2.43$4,387,160.88 5/31/2023Perceptive Advisors LlcDirectorBuy3,610,832$2.49$8,990,971.68 (Data available from 1/1/2013 forward) LYRA Insider Trading Activity - Frequently Asked Questions Who is on Lyra Therapeutics's Insider Roster? The list of insiders at Lyra Therapeutics includes C Ann Merrifield, Edward T Anderson, Harlan Waksal, Nbvm Gp, Llc, and Perceptive Advisors Llc. Learn more on insiders at LYRA. What percentage of Lyra Therapeutics stock is owned by insiders? 17.42% of Lyra Therapeutics stock is owned by insiders. Learn more on LYRA's insider holdings. Which Lyra Therapeutics insiders have been buying company stock? The following insiders have purchased LYRA shares in the last 24 months: C Ann Merrifield ($21,840.00), Harlan Waksal ($74,000.00), Nbvm Gp, Llc ($4,387,160.88), and Perceptive Advisors Llc ($8,990,971.68). How much insider buying is happening at Lyra Therapeutics? Insiders have purchased a total of 5,445,576 LYRA shares in the last 24 months for a total of $13,473,972.56 bought. More Insider Trading Tools from MarketBeat Related Companies: NEPH Insider Trading PAVM Insider Trading MDAI Insider Trading NMTC Insider Trading FEMY Insider Trading AKLI Insider Trading RVP Insider Trading ICU Insider Trading TTOO Insider Trading GCTK Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month 3 Companies Buying Back Cheap Stock LatelyPagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year This page (NASDAQ:LYRA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperDid Intel Just Dethrone Nvidia?Chaikin AnalyticsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAmerica’s worst nightmare?Porter & CompanyElon’s New Device is About to Shock the WorldInvestorPlaceClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.